SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-002146
Filing Date
2017-03-29
Accepted
2017-03-29 17:17:28
Documents
117
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231491z10-k.htm 10-K 1331389
2 EX-10.27 a2231491zex-10_27.htm EX-10.27 11871
3 EX-21.1 a2231491zex-21_1.htm EX-21.1 3381
4 EX-23.1 a2231491zex-23_1.htm EX-23.1 3671
5 EX-31.1 a2231491zex-31_1.htm EX-31.1 8012
6 EX-31.2 a2231491zex-31_2.htm EX-31.2 7996
7 EX-32.1 a2231491zex-32_1.htm EX-32.1 4565
8 EX-32.2 a2231491zex-32_2.htm EX-32.2 4521
15 G11223KOI001.JPG g11223koi001.jpg GRAPHIC 5036
  Complete submission text file 0001047469-17-002146.txt   8104878

Data Files

Seq Description Document Type Size
9 EX-101.INS ontx-20161231.xml EX-101.INS 1856977
10 EX-101.SCH ontx-20161231.xsd EX-101.SCH 89101
11 EX-101.CAL ontx-20161231_cal.xml EX-101.CAL 59748
12 EX-101.DEF ontx-20161231_def.xml EX-101.DEF 282556
13 EX-101.LAB ontx-20161231_lab.xml EX-101.LAB 639107
14 EX-101.PRE ontx-20161231_pre.xml EX-101.PRE 536234
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 17722981
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1